Health Canada Approves Eurofins CDMO Alphora Inc.'s Cannabis Drug License for Synthetic Phytocannabinoids

LUXEMBOURG, October 11, 2023--Eurofins CDMO Alphora Inc. announces that it has received its Health Canada Cannabis Drug License issued within the Cannabis Act and Cannabis Regulations for its Oakville, Ontario operations in September 2023. This compliments the Institutional Research License obtained through Health Canada in June 2021 for its Mississauga development site and a Standard Processing License obtained for the Oakville, Ontario manufacturing operation in May 2022.

Related Keywords

Oakville ,Ontario ,Canada ,Luxembourg ,United States ,India ,America ,Cheryl Young ,Eurofins Group ,Manufacturing Organization ,Institutional Research ,Kare Chemical Technologies Inc ,Health Canada Cannabis Drug ,Contract Development ,Alphora Inc ,Health Canada ,Vp Business Development Project Management ,Health Canada Cannabis Drug License ,Cannabis Act ,Cannabis Regulations ,Institutional Research License ,Standard Processing License ,Cannabis Drug License ,Kare Chemical Technologies ,North America ,Eurofins ,Ppi Development ,Are Chemical Technologies Inc ,